Suppr超能文献

治疗牙周疾病以预防孕妇不良分娩结局。

Treating periodontal disease for preventing adverse birth outcomes in pregnant women.

作者信息

Iheozor-Ejiofor Zipporah, Middleton Philippa, Esposito Marco, Glenny Anne-Marie

机构信息

Division of Nursing, Midwifery and Social Work, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Jean McFarlane Building, Oxford Road, Manchester, UK, M13 9PL.

出版信息

Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD005297. doi: 10.1002/14651858.CD005297.pub3.

Abstract

BACKGROUND

Periodontal disease has been linked with a number of conditions, such as cardiovascular disease, stroke, diabetes and adverse pregnancy outcomes, all likely through systemic inflammatory pathways. It is common in women of reproductive age and gum conditions tend to worsen during pregnancy. Some evidence from observational studies suggests that periodontal intervention may reduce adverse pregnancy outcomes. There is need for a comprehensive Cochrane review of randomised trials to assess the effect of periodontal treatment on perinatal and maternal health.

OBJECTIVES

To assess the effects of treating periodontal disease in pregnant women in order to prevent or reduce perinatal and maternal morbidity and mortality.

SEARCH METHODS

Cochrane Oral Health's Information Specialist searched the following databases: Cochrane Oral Health's Trials Register (to 6 October 2016), Cochrane Pregnancy and Childbirth's Trials Register (to 7 October 2016), the Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue 9) in the Cochrane Library, MEDLINE Ovid (1946 to 6 October 2016), Embase Ovid (1980 to 6 October 2016), and LILACS BIREME Virtual Health Library (Latin American and Caribbean Health Science Information database; 1982 to 6 October 2016). ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform were searched for ongoing trials on 6 October 2016. We placed no restrictions on the language or date of publication when searching the electronic databases.

SELECTION CRITERIA

We included all randomised controlled trials (RCTs) investigating the effects of periodontal treatment in preventing or reducing perinatal and maternal morbidity and mortality. We excluded studies where obstetric outcomes were not reported.

DATA COLLECTION AND ANALYSIS

Two review authors independently screened titles and abstracts and extracted data using a prepiloted data extraction form. Missing data were obtained by contacting authors and risk of bias was assessed using Cochrane's 'Risk of bias' tool. Where appropriate, results of comparable trials were pooled and expressed as risk ratios (RR) or mean differences (MD) with 95% confidence intervals (CI) . The random-effects model was used for pooling except where there was an insufficient number of studies. We assessed the quality of the evidence using GRADE.

MAIN RESULTS

There were 15 RCTs (n = 7161 participants) meeting our inclusion criteria. All the included studies were at high risk of bias mostly due to lack of blinding and imbalance in baseline characteristics of participants. The studies recruited pregnant women from prenatal care facilities who had periodontitis (14 studies) or gingivitis (1 study).The two main comparisons were: periodontal treatment versus no treatment during pregnancy and periodontal treatment versus alternative periodontal treatment. The head-to-head comparison between periodontal treatments assessed a more intensive treatment versus a less intensive one.Eleven studies compared periodontal treatment with no treatment during pregnancy. The meta-analysis shows no clear difference in preterm birth < 37 weeks (RR 0.87, 95% CI 0.70 to 1.10; 5671 participants; 11 studies; low-quality evidence) between periodontal treatment and no treatment. There is low-quality evidence that periodontal treatment may reduce low birth weight < 2500 g (9.70% with periodontal treatment versus 12.60% without treatment; RR 0.67, 95% CI 0.48 to 0.95; 3470 participants; 7 studies).It is unclear whether periodontal treatment leads to a difference in preterm birth < 35 weeks (RR 1.19, 95% CI 0.81 to 1.76; 2557 participants; 2 studies; ) and < 32 weeks (RR 1.35, 95% CI 0.78 to 2.32; 2755 participants; 3 studies), low birth weight < 1500 g (RR 0.80, 95% CI 0.38 to 1.70; 2550 participants; 2 studies), perinatal mortality (including fetal and neonatal deaths up to the first 28 days after birth) (RR 0.85, 95% CI 0.51 to 1.43; 5320 participants; 7 studies; very low-quality evidence), and pre-eclampsia (RR 1.10, 95% CI 0.74 to 1.62; 2946 participants; 3 studies; very low-quality evidence). There is no evidence of a difference in small for gestational age (RR 0.97, 95% CI 0.81 to 1.16; 3610 participants; 3 studies; low-quality evidence) when periodontal treatment is compared with no treatment.Four studies compared periodontal treatment with alternative periodontal treatment. Data pooling was not possible due to clinical heterogeneity. The outcomes reported were preterm birth < 37 weeks, preterm birth < 35 weeks, birth weight < 2500 g, birth weight < 1500 g and perinatal mortality (very low-quality evidence). It is unclear whether there is a difference in < 37 weeks, preterm birth < 35 weeks, birth weight < 2500 g, birth weight < 1500 g and perinatal mortality when different periodontal treatments are compared because the quality of evidence is very low.Maternal mortality and adverse effects of the intervention did not occur in any of the studies that reported on either of the outcomes.

AUTHORS' CONCLUSIONS: It is not clear if periodontal treatment during pregnancy has an impact on preterm birth (low-quality evidence). There is low-quality evidence that periodontal treatment may reduce low birth weight (< 2500 g), however, our confidence in the effect estimate is limited. There is insufficient evidence to determine which periodontal treatment is better in preventing adverse obstetric outcomes. Future research should aim to report periodontal outcomes alongside obstetric outcomes.

摘要

背景

牙周疾病与多种病症相关,如心血管疾病、中风、糖尿病及不良妊娠结局等,所有这些可能都通过全身炎症途径产生关联。牙周疾病在育龄女性中很常见,且牙龈状况在孕期往往会恶化。一些观察性研究的证据表明,牙周干预可能会减少不良妊娠结局。因此需要通过Cochrane系统评价对随机试验进行全面评估,以确定牙周治疗对围产期和孕产妇健康的影响。

目的

评估治疗孕妇牙周疾病对预防或降低围产期及孕产妇发病率和死亡率的效果。

检索方法

Cochrane口腔健康信息专家检索了以下数据库:Cochrane口腔健康试验注册库(截至2016年10月6日)、Cochrane妊娠与分娩试验注册库(截至2016年10月7日)、Cochrane图书馆中的Cochrane对照试验中央注册库(CENTRAL;2016年第9期)、MEDLINE Ovid(1946年至2016年10月6日)、Embase Ovid(1980年至2016年10月6日)以及LILACS BIREME虚拟健康图书馆(拉丁美洲和加勒比健康科学信息数据库;1982年至2016年10月6日)。2016年10月6日,检索了ClinicalTrials.gov和世界卫生组织国际临床试验注册平台以查找正在进行的试验。检索电子数据库时,我们未对语言或出版日期设限。

入选标准

我们纳入了所有研究牙周治疗对预防或降低围产期及孕产妇发病率和死亡率影响的随机对照试验(RCT)。我们排除了未报告产科结局的研究。

数据收集与分析

两位综述作者独立筛选标题和摘要,并使用预先设计的数据提取表提取数据。通过与作者联系获取缺失数据,并使用Cochrane的“偏倚风险”工具评估偏倚风险。在适当情况下,对可比试验的结果进行合并,并以风险比(RR)或均值差(MD)及95%置信区间(CI)表示。除研究数量不足外,均采用随机效应模型进行合并。我们使用GRADE评估证据质量。

主要结果

有15项RCT(n = 7161名参与者)符合我们的纳入标准。所有纳入研究大多因缺乏盲法和参与者基线特征不均衡而存在高偏倚风险。这些研究招募了来自产前保健机构的患有牙周炎(14项研究)或牙龈炎(1项研究)的孕妇。两项主要比较为:孕期牙周治疗与未治疗,以及牙周治疗与替代牙周治疗。牙周治疗之间的直接比较评估了强化治疗与非强化治疗。11项研究比较了孕期牙周治疗与未治疗。荟萃分析显示,在孕周<37周的早产方面,牙周治疗与未治疗之间无明显差异(RR = 0.87,95%CI 0.70至1.10;5671名参与者;11项研究;低质量证据)。有低质量证据表明,牙周治疗可能会降低出生体重<2500g的发生率(牙周治疗组为9.70%,未治疗组为12.60%;RR = 0.67,95%CI 0.48至0.95;3470名参与者;7项研究)。目前尚不清楚牙周治疗是否会导致孕周<35周(RR = 1.19,95%CI 0.81至1.76;2557名参与者;2项研究)和<32周(RR = 1.35, 95%CI 0.78至2.32;2755名参与者;3项研究)的早产、出生体重<1500g(RR = 0.80,95%CI 0.38至1.70;2550名参与者;2项研究)、围产期死亡率(包括出生后前28天内的胎儿和新生儿死亡)(RR = 0.85,95%CI 0.51至1.43;5320名参与者;7项研究;极低质量证据)以及子痫前期(RR = 1.10,95%CI 0.74至1.62;2946名参与者;3项研究;极低质量证据)出现差异。在与未治疗相比时,没有证据表明牙周治疗在小于胎龄儿方面存在差异(RR = 0.97,95%CI 0.81至1.16;3610名参与者;3项研究;低质量证据)。4项研究比较了牙周治疗与替代牙周治疗。由于临床异质性,无法进行数据合并。报告的结局为孕周<37周的早产、孕周<35周的早产、出生体重<2500g、出生体重<1500g和围产期死亡率(极低质量证据)。由于证据质量极低,尚不清楚比较不同牙周治疗时,在孕周<37周的早产、孕周<35周的早产、出生体重<2500g、出生体重<1500g和围产期死亡率方面是否存在差异。在报告了这两个结局中任何一个的研究中,均未发生孕产妇死亡和干预的不良反应。

作者结论

尚不清楚孕期进行牙周治疗是否会对早产产生影响(低质量证据)。有低质量证据表明,牙周治疗可能会降低低出生体重(<2500g),然而,我们对效应估计值的信心有限。没有足够的证据来确定哪种牙周治疗在预防不良产科结局方面更好。未来的研究应旨在同时报告牙周结局和产科结局。

相似文献

1
Treating periodontal disease for preventing adverse birth outcomes in pregnant women.
Cochrane Database Syst Rev. 2017 Jun 12;6(6):CD005297. doi: 10.1002/14651858.CD005297.pub3.
2
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3.
3
Chlorhexidine mouthrinse as an adjunctive treatment for gingival health.
Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD008676. doi: 10.1002/14651858.CD008676.pub2.
4
Iodine supplementation for women during the preconception, pregnancy and postpartum period.
Cochrane Database Syst Rev. 2017 Mar 5;3(3):CD011761. doi: 10.1002/14651858.CD011761.pub2.
5
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.
Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2.
6
Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.
Cochrane Database Syst Rev. 2018 Jan 5;1(1):CD012910. doi: 10.1002/14651858.CD012910.
7
Different insulin types and regimens for pregnant women with pre-existing diabetes.
Cochrane Database Syst Rev. 2017 Feb 3;2(2):CD011880. doi: 10.1002/14651858.CD011880.pub2.
8
Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.
Cochrane Database Syst Rev. 2017 Aug 3;8(8):CD007222. doi: 10.1002/14651858.CD007222.pub4.
9
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3.
10
Dietary advice interventions in pregnancy for preventing gestational diabetes mellitus.
Cochrane Database Syst Rev. 2017 Jan 3;1(1):CD006674. doi: 10.1002/14651858.CD006674.pub3.

引用本文的文献

3
Evaluation of the Effect of Supragingival Scaling on Periodontal Parameters in Pregnant Women with Metabolic Syndrome.
J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S3925-S3931. doi: 10.4103/jpbs.jpbs_1372_24. Epub 2024 Dec 10.
4
Interventions to Prevent and Manage Infections in Pregnancy.
Neonatology. 2025;122(Suppl 1):32-41. doi: 10.1159/000543690. Epub 2025 Jan 28.
7
The unrevealed links: periodontal health, human milk composition, and infant gut microbiome dynamics.
Prim Health Care Res Dev. 2024 Nov 14;25:e62. doi: 10.1017/S1463423624000215.

本文引用的文献

2
Use of mouth rinse during pregnancy to improve birth and neonatal outcomes: a randomized controlled trial.
BMC Pregnancy Childbirth. 2015 Nov 25;15:311. doi: 10.1186/s12884-015-0761-3.
5
Periodontal treatment for preventing adverse pregnancy outcomes: a meta- and trial sequential analysis.
PLoS One. 2015 Jun 2;10(6):e0129060. doi: 10.1371/journal.pone.0129060. eCollection 2015.
6
Periodontal treatment outcomes during pregnancy and postpartum.
Clin Oral Investig. 2015 Sep;19(7):1635-41. doi: 10.1007/s00784-014-1386-z. Epub 2014 Dec 18.
9
Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects.
J Clin Epidemiol. 2014 Mar;67(3):267-77. doi: 10.1016/j.jclinepi.2013.08.015. Epub 2013 Nov 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验